A detailed history of Bruce & Co., Inc. transactions in Personalis, Inc. stock. As of the latest transaction made, Bruce & Co., Inc. holds 300,000 shares of PSNL stock, worth $894,000. This represents 0.22% of its overall portfolio holdings.

Number of Shares
300,000
Previous 300,000 -0.0%
Holding current value
$894,000
Previous $630,000 29.05%
% of portfolio
0.22%
Previous 0.32%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 12, 2024

BUY
$0.93 - $2.35 $139,500 - $352,500
150,000 Added 100.0%
300,000 $630,000
Q1 2023

May 12, 2023

BUY
$2.01 - $4.17 $200,999 - $417,000
100,000 Added 200.0%
150,000 $413,000
Q4 2022

Feb 14, 2023

BUY
$1.78 - $2.87 $89,000 - $143,500
50,000 New
50,000 $99,000

Others Institutions Holding PSNL

About Personalis, Inc.


  • Ticker PSNL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 45,918,400
  • Market Cap $137M
  • Description
  • Personalis, Inc. operates as a cancer genomics company worldwide. The company provides sequencing and data analysis services to support the development of cancer therapies and large-scale genetic research programs. It offers NeXT Platform, which provides data analysis for tumor and its immune microenvironment, from a single limited tissue or pla...
More about PSNL
Track This Portfolio

Track Bruce & Co., Inc. Portfolio

Follow Bruce & Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bruce & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Bruce & Co., Inc. with notifications on news.